clinical trial · NCT04529954
Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion
Cerebral Therapeutics LLC·phase2·terminated·n = 20
Focal EpilepsyValproic Acid delivered to ICV
brief summary
This is a non-randomized open-label extension study for subjects having completed protocol DA071976 or CLN100P.01.
started
Jan 1, 2021
primary completion
Mar 1, 2024
completion
Mar 1, 2024
last updated
Mar 13, 2024
official title
An Open-Label Extension Study to Investigate the Long-Term Safety, and Tolerability of Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol